| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.03 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.04 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.05 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |